Real-world efficacy of direct acting antiviral therapies in patients with HIV/HCV.

Authors

Sonia Vibhakar Patel
Dushyantha T Jayaweera
Keri N Althoff
Joseph J Eron
Janna Radtchenko
Anthony Mills
Graeme Moyle
Steven Santiago
Paul E Sax
Jason Gillman
Karam Mounzer
Richard A. Elion, George Washington University
Gregory D Huhn

Document Type

Journal Article

Publication Date

2-13-2020

Journal

PLoS One

Volume

15

Issue

2

Inclusive Pages

e0228847

DOI

10.1371/journal.pone.0228847

Keywords

Adult; Aged; Antiviral Agents; Benzimidazoles; Carbamates; Coinfection; Drug Therapy, Combination; Female; Fluorenes; HIV Infections; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Heterocyclic Compounds, 4 or More Rings; Humans; Male; Middle Aged; Retrospective Studies; Ribavirin; Simeprevir; Sustained Virologic Response; Treatment Outcome; United States; Uridine Monophosphate; Viral Load

Comments

eCollection 2020

APA Citation

Patel, S., Jayaweera, D., Althoff, K., Eron, J., Radtchenko, J., Mills, A., Moyle, G., Santiago, S., Sax, P., Gillman, J., Mounzer, K., Elion, R. A., & Huhn, G. (2020). Real-world efficacy of direct acting antiviral therapies in patients with HIV/HCV.. PLoS One, 15 (2). http://dx.doi.org/10.1371/journal.pone.0228847

Peer Reviewed

1

Open Access

1